See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Avonex, Avonex Prefilled Syringe
What is Interferon beta 1a IM Injection? Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 30–35% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients.
See more information, including instructions, precautions, side effects, and interactions.
1163 patients in the community are taking or have taken Interferon beta 1a IM Injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 971 | 83% |
| Other | 48 | 4% |
| General health | 12 | 1% |
| Stiffness/spasticity | 8 | <1% |
| Fatigue | 7 | <1% |
| Don't know | 7 | <1% |
| Vision | 3 | <1% |
| disease-related symptoms | 3 | <1% |
| MS | 2 | <1% |
| Pain | 2 | <1% |
| Numbness, tingling, pins & needles (paresthesia) | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Sexual dysfunction | 1 | <1% |
| Bladder problems | 1 | <1% |
| Brain fog | 1 | <1% |
| Optic neuritis (inflammation of optic nerve) | 1 | <1% |
| Stuffy head and ear pain | 1 | <1% |
| Sensation | 1 | <1% |
| Mobility | 1 | <1% |
| Support another treatment | 1 | <1% |
Based on the patients currently taking Interferon beta 1a IM Injection.
Top 10 (Show all)
All (Show Top 10)
| 0 - Weekly | 0 mcg Weekly | 0 mg Weekly | 0 Weekly | 0.05 mcg Weekly | 0.25 mg Weekly | 0.3 mcg Weekly | 0.325 mcg Weekly | 0.5 mcg Weekly | 0.5 mg Weekly | 0.5 mL Weekly | 0.5 Weekly | 1 mcg Weekly | 1 mg Weekly | 1 mL Weekly | 1 Weekly | 1.5 mcg Weekly | 1.5 mg Weekly | 4 Weekly | 5 mcg Weekly | 10 mg Weekly | 13.2 mg Weekly | 2 mcg Daily | 15 mcg Weekly | 15 mg Weekly | 30 mcg Every Other Week | 20 mcg Weekly | 22 mcg Weekly | 24 mcg Weekly | 30 mcg Weekly | 30 mg Weekly | 30 Weekly | 33 mcg Weekly | 35 mcg Weekly | 35 mg Weekly | 37 mcg Weekly | 44 mg Weekly | 50 mcg Weekly | 60 mcg Weekly | 66 mcg Weekly | 80 mg Weekly | 100 mcg Weekly | 125 mcg Weekly | 132 mcg Weekly | 200 mcg Weekly | 30 mcg Daily | 30 mcg Weekly | 250 mcg Weekly | 44 mcg Daily | 360 mg Weekly | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3
|
119
|
35
|
27
|
1
|
1
|
1
|
1
|
6
|
2
|
1
|
2
|
18
|
12
|
1
|
10
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
370
|
24
|
10
|
5
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
7
|
13
|
6
|
1
|
1
|
1
|
||
How long current patients have been taking Interferon beta 1a IM Injection or how long patients were taking Interferon beta 1a IM Injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 196 | 45% | |
| Did not seem to work | 149 | 35% | |
| Doctor's advice | 113 | 26% | |
| Other | 87 | 20% | |
| Expense | 19 | 4% | |
| Personal research | 13 | 3% | |
| Not indicated | 10 | 2% | |
| Course of treatment ended | 1 | 0% |
Results from 110 patient evaluations. See the overall results and all individual evaluations.
| Major | 19% | 20 |
|---|---|---|
| Moderate | 16% | 16 |
| Slight | 8% | 8 |
| None | 11% | 11 |
| Can't tell | 47% | 48 |
Slow my MS progress
| Severe | 25% | 28 |
|---|---|---|
| Moderate | 35% | 38 |
| Mild | 33% | 36 |
| None | 7% | 8 |
Top reported side-effects include: Muscle ache, whole body, Chills/fever, Body Aches
Summary results are based on 110 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta 1a IM Injection